Abstract

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2015 - Volume 19, Number 1

Page(s): 38-40

Download in electronic PDF format for $75

Note: Electronic version includes supplemental material.

Abstract

The world of pharmaceuticals is changing rapidly as biotechnology continues to grow and nanotechnology appears on the horizon. Biotechnology is gaining in importance in extemporaneous pharmaceutical compounding, and nanotechnology and pharmacogenomics could drastically change the practice of pharmacy. This article discusses biotechnology and the factors to consider when compounding biotechnology drugs.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2015 Pg. 38-40	Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1 Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 446-466	Compounding with Biotechnology Products, Part 2: Product-specific Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 280-287	Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Author(s): Allen Loyd V
Sep/Oct 2022 Pg. 385-395	Compounding with Biotechnology Products, Part 1: General Considerations Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 223-228	Basics of Sterile Compounding: Manipulating Peptides and Proteins Author(s): Akers Michael J
May/Jun 2011 Pg. 234-238	Basics of Compounding: Basics of Compounding with Complex Organic Molecules Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 474-479	Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Author(s): Maham Nicole Y
Sep/Oct 2016 Pg. 367-374	Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Author(s): Kochanowska-Karamyan Anna J
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 396-400	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 305-311	Basics: Excipients Used in Nonsterile Compounding, Part 1 Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 305-310	Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Author(s): Vu Nicole, Lou Jessica R, Kupiec Thomas C
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2014 Pg. 6-12	The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Nov/Dec 2015 Pg. 471-476	Basic Principles of Lyophilization, Part 1 Author(s): Akers Michael J
Jan/Feb 2020 Pg. 38-43	Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 270-276	Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Sep/Oct 2019 Pg. 393-396	Basics: Excipients Used in Nonsterile Compounding, Part 2 Author(s): Allen Loyd V Jr